Analysis of Drug Planning and Control at the Pluit Hospital in 2015

Authors

  • Endang Setiawati Rumah Sakit Pluit
  • Anny Victor Purba Universitas Pancasila ,
  • Wahyudi Uun Hidayat Universitas Pancasila ,

DOI:

https://doi.org/10.35814/jifi.v18i1.782

Keywords:

Planning, Control, analysis ABC, VEN, Safety Stock, Reorder Point

Abstract

Drug planning at Pluit Hospital is carried out using a consumption method that is based on previous use. The purpose of this study was to determine the investment value and use of drug supplies based on a combination of consumption methods with ABC, VEN and Reorder Point (ROP) analysis. This research is a qualitative and quantitative descriptive study with retrospective data collection during the period May-October 2016 at Pluit Hospital. ABC analysis results based on the investment value of the total group A drug items have a percentage of 69.90%; group B 20.07% and group C 10.03%. ABC analysis results based on the use of group A 69.95%; group B 20.04% and group C 10.01%. VEN analysis results for group V 3.24% absorbed investment of 5.15%; group E 60.10% absorbed investment 76.56% and group N 36.66% absorbed investment 18.29%. Analysis of drug planning based on ABC and VEN methods has high, medium and low investment values, usage values ​​and NIK. While the analysis of drug control based on the method of Lead Time, Safety stock and Reorder Point guarantees the availability of drugs on an ongoing basis.

References

Downloads

Published

2020-04-24

Issue

Vol. 18 No. 1 (2020): JIFI

Section

Articles

License

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.